Showing results (91-100 of 192) with videos related to
Sort By:
Pageof 20
Advanced Nanobiomed Research|January 19, 2026
Self-Assembled Verteporfin Nanoparticles for Photodynamic and Light-Independent Therapy in GlioblastomaJohn A Quinlan, Kaylin Baumiller, Anandita Gaur, et al.Cancer Research|September 4, 2012
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 familyLynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al.Cancer Research|October 22, 2009
Identification of compounds selectively killing multidrug-resistant cancer cellsDóra Türk, Matthew D Hall, Benjamin F Chu, et al.Assay and Drug Development Technologies|June 25, 2009
A dual-fluorescence high-throughput cell line system for probing multidrug resistanceKyle R Brimacombe, Matthew D Hall, Douglas S Auld, et al.Trends in Molecular Medicine|July 15, 2018
Pluripotent Stem Cell Platforms for Drug DiscoveryKevin G Chen, Barbara S Mallon, Kyeyoon Park, et al.Molecular Cancer Therapeutics|November 8, 2014
The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicityKi-Eun Chang, Bih-Rong Wei, James P Madigan, et al.Molecular Cancer Therapeutics|September 16, 2008
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transportersMitsunori Okabe, Gergely Szakács, Mark A Reimers, et al.Journal of Medicinal Chemistry|May 27, 2005
Transmembrane inhibitors of P-glycoprotein, an ABC transporterNadya I Tarasova, Rishi Seth, Sergey G Tarasov, et al.Cancer Drug Resistance (Alhambra, Calif.)|February 11, 2026
Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transportersJacob S Roth, Hui Guo, Lu Chen, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Identification of antibody-drug conjugate payloads which are substrates of ATP-binding cassette drug efflux transportersJacob S Roth, Hui Guo, Lu Chen, et al.Pageof 20